Lilly wins ban of generic Strattera pending appeal

Back to TopCommentsE-mailPrintBookmark and Share

Eli Lilly and Co., the world’s biggest maker of psychiatric drugs, won a court order banning generic versions of the attention-deficit treatment Strattera until a patent appeal is decided.

The U.S. Court of Appeals for the Federal Circuit in Washington on Tuesday granted Lilly’s request to prevent sales until the court rules on a judge’s decision invalidating a patent on the medicine. The court, which specializes in patent law, has said it would hear the appeal quickly.

Strattera generated U.S. sales of $445.6 million last year. Sun Pharmaceuticals Industries Ltd., based in Mumbai, said earlier Tuesday that the U.S. Food and Drug Administration approved its application to sell a copy of the drug, known by its chemical name atomoxetine hydrochloride.

“Today’s ruling will prevent the launch of a generic version of Strattera while the court considers our appeal under an expedited briefing schedule,” Mark Taylor, a spokesman for Indianapolis-based Lilly, said in an e-mail.

Other companies seeking to sell copies of Strattera are Mylan Inc., Teva Pharmaceutical Industries Ltd.; Novartis AG’s Sandoz unit; Synthon BV; Iceland’s Actavis Group hf; Canada’s Apotex Inc.; and India’s Aurobindo Pharma Ltd., Glenmark Pharmaceuticals Ltd., and Cadila Healthcare Ltd.’s Zydus.


Post a comment to this story

We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
You are legally responsible for what you post and your anonymity is not guaranteed.
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
Subscribe to IBJ